Alzheimer's disease (AD) is characterized by the appearance in the brain of plaques -containing extracellular deposits of amyloid ß-peptide (Aß) that result from altered proteolytic processing of amyloid precursor protein -together with intracellular neurofibrillary tangles containing misfolded tau (1). Brain regions with plaques and tangles exhibit reduced numbers of synapses, and neurites associated with plaques and tangles are often damaged, suggesting a pivotal role for Aß in the neuropathology of AD (2-5). Moreover, numerous other neurodegenerative disorders (including Huntington's, Parkinson's and prion diseases) are also associated with the formation and accumulation of amyloid fibrils in specific brain areas (6,7). These commonalities suggest a general mechanism of action for the more than 100 human amyloid-related diseases, whereby normally soluble peptides and proteins undergo aberrant folding (8).
Introduction
Alzheimer's disease (AD) is characterized by the appearance in the brain of plaques -containing extracellular deposits of amyloid ß-peptide (Aß) that result from altered proteolytic processing of amyloid precursor protein -together with intracellular neurofibrillary tangles containing misfolded tau (1) . Brain regions with plaques and tangles exhibit reduced numbers of synapses, and neurites associated with plaques and tangles are often damaged, suggesting a pivotal role for Aß in the neuropathology of AD (2) (3) (4) (5) . Moreover, numerous other neurodegenerative disorders (including Huntington's, Parkinson's and prion diseases) are also associated with the formation and accumulation of amyloid fibrils in specific brain areas (6, 7) . These commonalities suggest a general mechanism of action for the more than 100 human amyloid-related diseases, whereby normally soluble peptides and proteins undergo aberrant folding (8) .
Aggregation of Aß proceeds through several conformational states, including dimers, spherical oligomers composed of 10-24 monomers and strings of oligomers (protofibrils), before finally assuming an insoluble fibrillar conformation (9) . The initial formulation of the "amyloid hypothesis" of AD specifically implicated fibrillar amyloid deposits (10) . However, more recent evidence suggests that soluble oligomers may be the principal neurotoxic agent (11) (12) (13) (14) (15) . Soluble Aß  oligomers are found in the cerebrospinal fluid of AD patients (12) : the soluble Aß  content of human brain is better correlated with the severity of the disease than are the classical amyloid plaques containing insoluble Aß deposits (12, 16) : and fibril-free oligomers are toxic to cultured cells and neurons (11, 15, 17) . Moreover, soluble oligomeric forms of several amyloids (including islet amyloid polypeptide (IAPP), α-synuclein, prion, and polyglutamine) are respectively implicated as the primary toxic species in type 2 diabetes mellitus, Parkinson's disease, spongiform encephalopathies, and Huntington's disease (6, 15, 18) . This toxicity of amyloid oligomers appears to be intrinsically related to their aggregation state, because oligomeric forms of proteins and peptides that are not diseaserelated are equally toxic (14, 19) . Taken together, these findings support the notion of 'conformational disease' (20) , whereby a common structural motif formed by otherwise unrelated amyloid oligomers leads to a common mechanism of pathogenesis (14, 15) . However, it remains to be established precisely which aggregation state is primarily responsible for the neurotoxicity; and difficulties in preparing highly homogeneous and stable populations of monomers, oligomeric intermediates and fibrils may account for observations of highly variable actions among different cells (21) .
Questions also remain regarding the mechanism of amyloid toxicity. Growing evidence points to a disruption of intracellular Ca 2+ homeostasis in AD and other amyloidogenic diseases (1, 21, 22) , and elevated intracellular Ca 2+ levels are known to trigger apoptosis and/or excessive phosphorylation of key proteins that ultimately lead to cell death (23) (24) (25) (26) (27) (28) . Pre-fibrillar amyloid aggregates have been shown to elevate cytosolic Ca 2+ in neurons (19, 21) , but such actions have been proposed to be secondary to the generation of reactive oxygen species (1, 29) ; to arise from activation of cell surface receptors coupled to Ca 2+ influx (22, (30) (31) (32) ; or to result from Ca 2+ influx across the plasma membrane as a result of either cation-selective channels formed by Aß itself (21, 33) or through a general disruption of lipid integrity (34) .
To address these issues we prepared pure samples of monomeric, oligomeric and fibrillar forms of several disease-related amyloids and examined their respective actions on cytosolic Ca 2+ levels in SH-SY5Y cells. We show that amyloid oligomers consistently produce rapid and dramatic elevations in [Ca 2+ ], whereas equivalent concentrations of monomers or fibrils do not. The action of amyloid oligomers appears to involve a channel-independent disruption of the integrity of both plasma and intracellular membranes, and we propose that this may be a neurotoxic mechanism common to many amyloidogenic diseases.
Materials and Methods
Materials -Fluorescent dyes (fluo-3AM, calcein) and thapsigargin were from Molecular Probes (Eugene, OR). Ionomycin, cell culture media and other reagents were obtained from Sigma-Aldrich. Peptides were synthesized as described previously (35). Lyophilized peptides and proteins were resuspended in 50% acetonitrile in water and re-lyophilized. Preparation of homogeneous populations of amyloid peptide monomers, oligomers and fibrils. -Soluble monomer and oligomers were prepared by dissolving 1.0 mg of peptide in 400 µl hexafluoroisopropanol (HFIP) for 10-20 min at room temperature. 100 µl of the resulting seedless solution was added to 900 µl double-distilled water in a siliconized Eppendorf tube. After 10-20 min incubation at room temperature, the samples were centrifuged for 15 min at 14,000 x G and the supernatant fraction (pH 2.8-3.5) was transferred to a new siliconized tube and subjected to a gentle stream of N 2 for 5-10 min to evaporate the HFIP.
The monomer solutions were used immediately after evaporation of HFIP. For soluble oligomers, the samples were then stirred at 500 rpm using a Teflon-coated micro stir bar for 24-48 h at 22ºC. Aliquots (10 µl) were taken at 6-12h intervals for observation by electron microscopy (EM) and size exclusion chromatography (SEC). For prion 106-126, the samples were heated at 65ºC for 30min before stirring. Poly Q was heated for 2h at 37ºC. Fibrils were prepared as described above for oligomers, except they were stirred at room temperature for 6-9 days and sodium azide was added (0.02%). The final peptide concentration was 0.3 mg/ml. Fibril formation was monitored by thioflavin T fluorescence and UV light scattering. Once fibril formation was complete, the solutions were centrifuged at 14,000 x G for 20min, the fibril pellet was washed three times with double-distilled water, and then resuspended in the desired buffer. The morphology was verified by negative stain EM as previously reported (34) . Cell culture and dye loading -SH-SY5Y human neuroblastoma cells were maintained in Dulbecco`s modified Eagle`s medium (DMEM) (Gibco) supplemented with 10% fetal bovine serum, glutamine (4 mM), penicillin (200unit/ml), streptomycin (200 µg/ml), and sodium pyruvate (1 µM). Cells were maintained at 37°C in 5% CO 2 and the medium was replaced every 2 days. Cells (~10,000) were plated in 35mm glass-bottom culture dishes (MatTek Corporation) and grown overnight. Loading with the Ca 2+ indicator fluo-3 was accomplished by incubating with fluo-3-AM (7 µM in Hank's Balanced Salt Solution) for 30 min at room temperature, washing 3 times with HBSS and maintaining at 37°C for 20 min to ensure complete hydrolysis.
A similar loading protocol was utilized to load cells with calcein, by incubating with 7 µM calcein-AM.
Fluorescence Imaging -
The imaging system consisted of an inverted microscope (Olympus IX 71) equipped with a Leitz 16X objective. Fluorescence excitation was by a 488 nm argon ion laser, and emitted fluorescence (λ >510 nm) was imaged by a cooled c.c.d. camera (Cascade 650, Roper Scientific). Time-lapse images (1 frame s -1 ) were captured using the MetaMorph software package (Universal Imaging, Westchester, PA), and fluorescence intensities were measured from regions of interest centered on individual cells. Signals are expressed as a pseudo ratio (∆F/F) of the change in fluorescence (∆F) divided by the resting fluorescence before treatment (F). A small proportion (9 %) of cells failed to load with fluo-3, having low initial fluorescence and failing to respond to ionomycin. These were excluded from analysis.
Amyloids were applied by pipetting a fixed aliquot (70 µl) of a diluted stock solution into the recording chamber (1 ml volume) directly above the microscope objective. To estimate the resulting concentration experienced by the cells under observation we pipetted the same volume of a fluorescent dye (calcein) into the chamber, and measured the resulting fluorescence in the vicinity of the cells relative to that of the initial, undiluted solution of dye. This calibration yielded a dilution factor of about 5, which was assumed in calculating the effective concentrations of amyloids.
To avoid complications from differences in molecular weights between monomers, oligomers and fibrils, we express these concentrations in units of µg ml -1 . As a rough guide, a concentration of 0.6 µg ml -1 Aß42 corresponds to 200 nM monomer, and approximately 7 nM oligomer and 70 pM fibrils.
RESULTS
Aß42 oligomers, but not monomers or fibrils, increase intracellular free Ca 2 -Homogeneous populations of monomeric, oligomeric and fibrillar Aß were prepared as described above and characterized by size exclusion chromatography and electron microscopy. The oligomeric preparation had an approximate molecular mass of 90 kDa, contained very little material of lower molecular mass, and was comprised of spherical vesicles with diameters of 2-5 nm (Figure 1 ). The monomeric preparation contained no detectable oligomeric aggregates as analyzed by size exclusion chromatography (Figure 1 ). The morphology of the fibrillar preparations was as previously published (34) .
The actions of homogeneous monomeric, oligomeric and fibrillar preparations of soluble Aß42 amyloid were examined by adding aliquots of the samples to fluo-3 loaded SH-SY5Y cells ( Figure. 2). The fact that monomeric and fibrillar samples were inactive rules out the possibility that the increase in Ca 2+ was due to trace contaminants in the solvent, because the solvent remained the same over the time of incubation for the conversion of monomer to oligomer and then ultimately to fibrils. Solvent controls in the absence of peptide had no effect on Ca 2+ levels (data not shown).
Actions of other disease-related amyloids -
To explore the possibility of a common neurotoxic mechanism among amyloidogenic diseases, we selected five disease-related amyloid peptides (Aß42, prion, IAPP, polyglutamine, and lysozyme) and tested the effects of purified monomers, oligomers and fibrils of each of these amyloids on cytosolic Ca 2+ . Figure 3A illustrates representative fluorescence records obtained with IAPP at a concentration of 6 µg ml Figure 3A, traces a, b) . In marked contrast, equivalent amounts of purified IAPP oligomers produced a large fluorescence signal ( Figure 3A, trace c) , closely resembling the response evoked by Aß42 oligomers.
Mean results obtained with all five amyloids are summarized in Figure 3B . Figure 4A , and involved sequential additions of oligomer to the imaging chamber, resulting in stepwise increases in concentration. Concentrations of IAPP oligomer as low as 0.6 µg/ml (corresponding to 7.5 nM assuming a molecular mass of 80 kDa) already evoked a detectable fluorescence increase, and 12 µg/ml (about 150 nM) produced a maximal response, as assessed by the failure of ionomycin to cause any further increase in fluorescence (not shown). Figure 4B shows 2+ from intracellular stores into the cytosol, but subsequent application of Aß42 oligomers produced a large, rapid increase, similar to that observed in control cells without thapsigargin treatment ( Figure 5B) .
We examined the possibility that amyloidogenic peptides may induce Ca 2+ influx via endogenous Ca 2+ -permeable plasma membrane ion channels (30, 31) by applying Aß42 oligomers (6 µg/ml ) in the presence of 20 µM cobalt, a non-specific Ca 2+ channel blocker ( Figure 5A ). Fluorescence signals were of almost identical amplitude in the presence (black trace) and absence (gray trace) of cobalt, suggesting that Ca 2+ entry through cobalt-sensitive plasma membrane channels does not contribute significantly to the oligomer-induced rise in cytosolic [ Figure. 6 indicate that this decay does not reflect a fall in cytosolic free [Ca 2+ ], but rather that Aß42 induces a general increase in membrane permeability, thereby allowing leakage of dye into the extracellular medium.
Firstly, ionomycin failed to induce any rise in fluorescence when applied late in the decay phase of a response to Aß42 oligomers (Fig. 6A) . Secondly, Aß42 oligomers evoked an almost complete loss of fluorescence from cells loaded with the Ca 2+ -and pH-insensitive dye calcein ( Figure. 
DISCUSSION

We
show that extracellular applications of spherical oligomeric forms of Aß42 and several other disease-related amyloidogenic proteins and peptides cause an immediate and large increase in cytosolic free [Ca 2+ ], whereas equivalent amounts of monomeric and fibrillar forms are without any detectable effect. These results, obtained with highly homogeneous preparations, support a growing body of evidence that the aggregation state of these amyloids, rather than their specific amino acid sequences, is the key factor determining their toxicity (14, 15) .
Several mechanisms have been proposed to account for the Ca 2+ mobilizing actions of amyloids in their oligomeric and fibrillar aggregation states. These include a direct interaction with membrane components to destabilize the membrane structure (36) (37) (38) (39) ; insertion into the membrane to form a cationconducting pore (21, 34, (40) (41) (42) (43) (44) ; activation of cell surface receptors coupled to Ca 2+ influx (30) (31) (32) ; and oxidative stress leading to dysregulation of mitochondrial Ca 2+ homeostasis (1). Among these possibilities, our data favor the hypothesis of a generalized increase in membrane permeability induced specifically by spherical amyloid oligomers. The rise in cytosolic Ca 2+ following addition of oligomers is so rapid (one or a few seconds) as to preclude it being a secondary effect resulting from metabolic impairment and reduced Ca 2+ pumping or sequestration. Moreover, several observations argue against Ca 2+ influx through either endogenous Ca 2+ membrane channels, or through cationselective channels formed by the amyloid proteins themselves. Firstly, Ca 2+ signals were not reduced in the presence of 20 µM cobalt, a non-specific blocker of many Ca 2+ -permeable channels (45), or after applying CNQX to block Ca 2+ -permeable AMPA receptor/channels (22) . Secondly, all the amyloid oligomers we tested induced a rapid leakage of fluorescent dyes from cells loaded with fluo-3 and calcein, in agreement with a reports showing release of dye from phospholipid vesicles (46,47). Both fluo-3 and calcein are polyanionic molecules that are not expected to permeate through cation-selective channels, and have molecular masses (respectively, 854 and 622 Da) greater than the size cut-off for most ion channels. Finally, we note that although the major part of the oligomer-induced Ca 2+ elevation arose through entry of extracellular Ca 2+ ions, a remaining component in Ca 2+ -free medium points to liberation of Ca 2+ from intracellular stores. We thus propose that amyloid oligomers exert an immediate action by increasing the permeability of the plasma membrane, and subsequently penetrate into cells, as previously proposed (19) , where they similarly disrupt intracellular membranes to cause leakage of sequestered Ca 2+ . Given the non-specific increase in membrane permeability, it is probable that amyloid oligomers will disrupt the intracellular homeostasis of many ions and other cellular constituents in addition to Ca 2+ . Their actions on Ca 2+ signaling are, however, likely to mediate the major cytotoxic effects. Firstly, resting cytosolic free [Ca 2+ ] is normally maintained at very low levels despite enormous trans-membrane concentration gradients, so that even a small increase in Ca 2+ permeability will result in a proportionately large elevation of cytosolic [Ca 2+ ]. In agreement, Ca 2+ signals were evident at concentrations of oligomers that failed to induce any detectable dye leakage. Secondly, Ca 2+ dyshomeostasis is definitively implicated in both necrotic and apoptotic cell death (23) , and amyloid-induced Ca 2+ changes are directly correlated with cell viability (19). Nevertheless, it remains possible that perturbations of other ions and molecules may contribute to the long term pathogenesis of amyloid diseases. An intriguing possibility in neurological diseases is that an enhanced plasma membrane ion conductance may cause a sustained depolarization and increased electrical excitability, leading to excitotoxic injury.
We observed half-maximal Ca 2+ elevations with Aß and IAPP oligomers at concentrations of about 3 µg ml -1 , and consistent signals remained at 0.6 µg ml -1 (equivalent to about 7 nM). These concentrations are considerably lower than used in most previous studies, and the Ca 2+ signals were immediate, rather than rising over several minutes or after long latencies (19, 21) , possibly reflecting a higher purity of the active amyloid oligomers in our preparations. In comparison to the levels of soluble Aß measured in the brain of AD patients, however, the oligomer concentrations required to evoke immediate Ca 2+ signals are 100 -1000 times greater (12) . The obvious difference is that whereas high concentrations of amyloid oligomers evoke an acute and dramatic increase in cytosolic free [Ca 2+ ], the pathophysiology of AD likely involves the cumulative effects of a much smaller but chronic disruption of Ca 2+ homeostasis over several years. Moreover, the Ca 2+ mobilizing action of Aß oligomers may be only one mechanism contributing toward Ca 2+ signaling disruptions as a common pathway for neurotoxicity in AD. Early-onset AD is associated with mutations in the presenilin (PS) genes, and neurons from knock-in mice expressing an AD-linked mutation in PS1 display greatly exaggerated release of Ca 2+ from intracellular stores (48) . Fig. 1 . Size exclusion chromatography and morphology of pure Aß42 oligomers. The homogeneity and purity of Aß42 monomer and oligomer preparations were analyzed using size exclusion chromatography. Oligomers eluted between 12 and 15 min, which corresponds to an approximate molecular weight of 90,000 Da. Monomers eluted between 22 and 25 min. Inset image shows typical spherical oligomers (~3-5nm in diameter) formed after 48h of stirring. 
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